Who Just Raised
Get Pro

Newton, MA · Health Care · Form D filed Aug 13, 2026

Abcuro, Inc. raised $39.4M

Abcuro, Inc. is a biotechnology company based in Newton, Massachusetts. In a Form D filed with the SEC on August 13, 2026, it reported raising $39,383,108 from 23 investors as part of an offering of up to $176,522,953. The first sale in the offering took place on August 7, 2026.

The determination of people living with inclusion body myositis inspires our work and strengthens our resolve to advance precision therapies with the potential to change what's possible.

$255M raised since 2020

4 Form D offerings, as reported to the SEC, the first in Jul 6, 2020. Amendments update a round; they aren't counted twice.

FiledSoldOffering sizeInvestors
Aug 13, 2026$39.4M$177M23
Feb 19, 2025$80M$200M21
Aug 25, 2023$120M$200M21
Jul 6, 2020$15.5M$42M15

Lead score

33 out of 100

still raising budget to spend website found

Outreach kit How it works 1:21

A first message that shows you did your homework, written from this filing. Fill in the brackets and send.

Email · subject: Congrats on the new round

Hi [first name],

Congrats on the new round. I saw the raise in your SEC filing.

Teams at this stage usually start looking at [what you do] right after a round...

[Your name]

LinkedIn note

Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?

Call opener

Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...

Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing

Track this company How it works 0:56

Saved to your dashboard pipeline, with a badge in Explore.

Loading your outreach kit…

The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.

Start your free trial Already on Pro? Sign in

Filing details

Website
abcuro.com
Amount raised
$39,383,108
Offering size
$176,522,953
Investors so far
23
First sale
August 7, 2026
Securities offered
Equity
Exemption claimed
Rule 506(b)
Industry
Biotechnology
Headquarters
Newton, Massachusetts
Incorporated
Delaware
Entity type
Corporation

Filings

FiledFormRaisedOffering sizeInvestorsSource
D (new notice) $39,383,108 $176,522,953 23 SEC filing

Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.

Updated · Raises in the week of Aug 10, 2026 · Health Care funding in Massachusetts · August 2026 funding report

Health Care $2.6M

Axelyf, Inc.

Chestnut Hill, MA · filed Oct 13

2nd Form D since 2025

Health Care $850K

Soterya, Inc.

Boston, MA · filed Oct 13

First Form DStill raising

Health CareNo press found $1.2M

Bioventrix, Inc.

Mansfield, MA · filed Oct 8

OUR VISION: Extend Life Span and Improve Quality of Life for Heart Failure Patients OUR VISION Extending Life Span and Improving Quality of Life for Heart Failure Patients How Revivent Therapy May…

26th Form D since 2009Still raising

Health Care $15M

Revbio, Inc.

Lowell, MA · filed Oct 2

TETRANITE is a regenerative bone glue. Bioengineered for a body of applications, TETRANITE® promises to transform bone repair.

4th Form D since 2019

Health Care $681K

Opus KSD, Inc.

Pembroke, MA · filed Oct 1

3rd Form D since 2016

Health Care $10M

Xact Bio, Inc.

Boston, MA · filed Sep 28

First Form DStill raising

Health Care $1.5M

AutoIVF, Inc.

Natick, MA · filed Sep 25

4th Form D since 2020

Who Just Raised Pro

The raises that matter to you, in your inbox every weekday morning.

Your sectors, states and deal size · first-time vs repeat raisers · open rounds · a watchlist · every raise as a spreadsheet each Monday.